/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Douglas S. Hawkins

Seattle Children's Hospital(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

481

Papers

21.2K

Citations

71

h-index

224

i10-index

Douglas S. Hawkins is an academic researcher from Seattle Children's Hospital. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Tumors and Oncological Cases & Cancer-related molecular mechanisms research. The author has an h-index of 71, co-authored 409 publications.

ORCID: 0000-0003-3602-1375

Research Topics

Sarcoma Diagnosis and Treatment Tumors and Oncological Cases Cancer-related molecular mechanisms research Neuroblastoma Research and Treatments Childhood Cancer Survivors' Quality of Life

Papers by this author

works

Rhabdomyosarcoma

2019 · Nature Reviews Disease Primers · 824 citations

https://doi.org/10.1038/s41572-018-0051-2

Stephen X. Skapek Andrea Ferrari Abha A. Gupta Philip J. Lupo

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

2019 · European Journal of Cancer · 700 citations

https://doi.org/10.1016/j.ejca.2018.11.027

Sigbjørn Smeland Stefan Bielack Jeremy Whelan Mark L. Bernstein

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

2016 · The Lancet Oncology · 517 citations

https://doi.org/10.1016/s1470-2045(16)30214-5

Neyssa Marina Sigbjørn Smeland Stefan Bielack Mark L. Bernstein

Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study

2012 · Pediatric Blood & Cancer · 122 citations

https://doi.org/10.1002/pbc.24457

Stephen X. Skapek James R. Anderson David A. Hill David W. Henry

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

2023 · JNCI Journal of the National Cancer Institute · 82 citations

https://doi.org/10.1093/jnci/djad085

Susan Chi P. Mickey Williams Sinchita Roy‐Chowdhuri

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

2022 · European Journal of Cancer · 65 citations

https://doi.org/10.1016/j.ejca.2022.05.036

Simone Hettmer Corinne M. Linardic Anna Kelsey Erin R. Rudzinski

Research topics

topics

Sarcoma Diagnosis and Treatment

Tumors and Oncological Cases

Cancer-related molecular mechanisms research

Neuroblastoma Research and Treatments

Childhood Cancer Survivors' Quality of Life

Chat about Author

Papers

Chat

Click to start Chat